1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
  4. > Generics in Brazil

Generics in Brazil

  • January 2017
  • -
  • MarketLine
  • -
  • 31 pages

Summary
Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Findings
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil
- Leading company profiles reveal details of key generics market players' global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume

Synopsis
Essential resource for top-line data and analysis covering the Brazil generics market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Reasons To Buy
- What was the size of the Brazil generics market by value in 2016?
- What will be the size of the Brazil generics market in 2021?
- What factors are affecting the strength of competition in the Brazil generics market?
- How has the market performed over the last five years?
- How large is Brazil's generics market in relation to its regional counterparts?

Key Findings
For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.

The Brazilian generics market is expected to generate total revenues of $3.9bn in 2016, representing a compound annual growth rate (CAGR) of 3.9% between 2012 and 2016.

Market consumption volume is forecast to increase with a CAGR of 3.6% between 2012 and 2016, to reach a total of 26.3% of total pharma volume in 2016.

Fierce competition among local players has continued to drive the growth in the market's volume. However, the same fierce competition has led to aggressive discounts, which had affected the value of the market.

Table Of Contents

Generics in Brazil
Table of Contents
Executive Summary
Market value
Market value forecast
Market volume
Market volume forecast
Geography segmentation
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market volume
Market Segmentation
Geography segmentation
Market Outlook
Market value forecast
Market volume forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
O Ache Laboratorios Farmaceuticos S.A.
EMS Sigma Pharma
Eurofarma Laboratórios S.A.
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Brazil generics market value: $ billion, 2012-16(e)
Table 2: Brazil generics market volume: % of total pharma volume, 2012-16(e)
Table 3: Brazil generics market geography segmentation: $ billion, 2016(e)
Table 4: Brazil generics market value forecast: $ billion, 2016-21
Table 5: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Table 6: O Ache Laboratorios Farmaceuticos S.A.: key facts
Table 7: EMS Sigma Pharma: key facts
Table 8: Eurofarma Laboratórios S.A.: key facts
Table 9: Sanofi SA: key facts
Table 10: Sanofi SA: key financials ($)
Table 11: Sanofi SA: key financials (€)
Table 12: Sanofi SA: key financial ratios
Table 13: Brazil size of population (million), 2012-16
Table 14: Brazil gdp (constant 2005 prices, $ billion), 2012-16
Table 15: Brazil gdp (current prices, $ billion), 2012-16
Table 16: Brazil inflation, 2012-16
Table 17: Brazil consumer price index (absolute), 2012-16
Table 18: Brazil exchange rate, 2012-16

List of Figures
Figure 1: Brazil generics market value: $ billion, 2012-16(e)
Figure 2: Brazil generics market volume: % of total pharma volume, 2012-16(e)
Figure 3: Brazil generics market geography segmentation: % share, by value, 2016(e)
Figure 4: Brazil generics market value forecast: $ billion, 2016-21
Figure 5: Brazil generics market volume forecast: % of total pharma volume, 2016-21
Figure 6: Forces driving competition in the generics market in Brazil, 2016
Figure 7: Drivers of buyer power in the generics market in Brazil, 2016
Figure 8: Drivers of supplier power in the generics market in Brazil, 2016
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2016
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2016
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2016
Figure 12: Sanofi SA: revenues and profitability
Figure 13: Sanofi SA: assets and liabilities

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Blood Typing, Grouping and Infectious Disease Screening Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Transfusion Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Middle East--Volume and Sales Forecasts for 40 Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 43500
  • Industry report
  • January 2017
  • by Venture Planning Group

This comprehensive 68-country report from VPGMarketResearch.com provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market ...


ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.